DUBLIN–(BUSINESS WIRE)–The “Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides 2023 to 2027” report has been added to ResearchAndMarkets.com’s offering.
The healthcare sector is on the cusp of a revolution with the latest advancements in diagnostic technologies geared towards combatting antimicrobial resistance (AMR). This new comprehensive research publication analyzes the burgeoning market and the potential these technologies hold in the fight against one of the most pressing healthcare challenges of our time.
This report presents an in-depth analysis of the AMR diagnostic market, providing a clear understanding of the various diagnostic methods emerging to identify pathogens and infections. It dissects the new diagnostic technologies beyond gene sequencing that are gaining traction in this evolving market landscape.
The research underscores the strategic market opportunities against AMR by detailing the six key large pathogen opportunities poised for significant growth. This is an indispensable insight for industry investors and healthcare stakeholders seeking to stay ahead of the curve in a rapidly changing market.
Furthermore, the report offers a comprehensive profiling of over 30 companies actively involved in developing groundbreaking diagnostic solutions. These profiles include established industry giants as well as nascent players who are introducing innovation and driving growth in the AMR diagnostic space.
Apart from the technological evaluation and strategic market insights, the document delves into the trends influencing the global AMR diagnostics market from 2023 to 2027. It is instrumental for formulating data-driven decisions and aligning business strategies with the market dynamics.
The insights provided in the report are crucial for industry professionals, healthcare providers, and policy-makers who are navigating the challenges of antimicrobial resistance. It serves as a roadmap to understanding the evolving technologies and market strategies that will play a crucial role in the global healthcare system.
Plain language analysis of the diverse diagnostic techniques
Forecasted market data for major pathogen diagnostic opportunities
Extensive company profiles spanning major industry participants
Valuable perspectives on emerging trends and market growth areas
As the healthcare industry grapples with the enormity of antimicrobial resistance, this report is an essential resource providing clarity and direction for those at the forefront of medical diagnostics innovation.
Key Topics Covered:
Antibiotic Resistance Diagnostics Recent Developments
Antibiotic Resistance Recent Developments
FDA Clears New bioMerieux Diagnostic System and Panel
Selux Diagnostics Phenotyping System Gets FDA Approval
New diagnostics to tackle drug resistant infections
Takara Bio USA, Inc. and BioExcel Diagnostics Partner for Infectious Disease Panels
Three companies join forces to tackle antimicrobial resistance (AMR)
T2 Biosystems Exercises BARDA Option
OpGen to Ramp up Use of Acuitas AMR Gene Panel
BD Partners With Pfizer, Wellcome to Study AMR Dx
Sepsis Test Developers Accelerate Plans
OpGen Receives FDA Clearance for AMR Panel
Visby Medical – Rapid Uptake of Handheld PCR Test for STIs
MicroGenDx, OrthoKey Clinic and OrthoKey Surgery
BioMerieux Receives CE Mark for Vitek Clinical Microbiology System
Hologic to Acquire Mobidiag
Campylobacter strains exchange genes
Disinfection spreads antimicrobial resistance
Molzym, Fraunhofer Developing Rapid Sepsis Dx
Illumina, IDbyDNA Build NGS-Based Respiratory Panel
Accelerate Diagnostics Expands AMR Testing
Rapid diagnostics linked to optimal antibiotics
Visby Medical Wins AMR Diagnostic Competition
DNAe Technology SARS-CoV-2 Sequences
Infections with foodborne bacteria becoming harder to treat
Dust is sharing antibiotic resistance genes
Key AMR Diagnostics Companies
1928 Diagnostics
Abacus Diagnostica
Abbott Laboratories
Accelerate Diagnostics
ADT Biotech
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Binx Health
bioMérieux Diagnostics
Bio-Rad Laboratories, Inc.
Cepheid (Danaher)
Curetis N.V. / Curetis GmbH
Day Zero Diagnostics.
Enzo Biochem
Eurofins Scientific
Fusion Genomics.
GeneFluidics
Genetic Signatures
Great Basin Corporation
Hologic
Hutman Diagnostics
Inflammatix
Linear Diagnostics.
Lumos Diagnostics
Millipore Sigma
OpGen
Ortho Clinical Diagnostics
Perkin Elmer
Qiagen
Roche Molecular Diagnostics
SeLux Diagnostics
Sense Biodetection
Siemens Healthineers
Sysmex
Thermo Fisher Scientific Inc.
Visby Medical
The Global Market for Antimicrobial Resistance Diagnostics
Global Antibiotic Resistance Diagnostic Markets – By Pathogen
Global Antibiotic Resistance Diagnostic Markets – by Technology
Vision of the Future of AMR Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/dm4ikm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900